Oncology
1 drug is in development for Urologic Cancer.
- Companies
- 1
- Clinical trials
- 7
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Urologic Cancer pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| ndv-01 | RELMADA THERAPEUTICS, INC. (RLMD) |
About this indication
Urologic Cancer context
Oncology·MeSH: Urologic Neoplasms (D014571)
Narrower concept of MeSH descriptor Urologic Neoplasms
Frequently asked questions
How many drugs are in development for Urologic Cancer?
BioSniper tracks 1 drug in development for Urologic Cancer across 1 company.
How many clinical trials target Urologic Cancer?
There are 7 clinical trials targeting Urologic Cancer tracked by BioSniper.